Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-pandemic impact on the epidemiology of invasive pneumococcal disease: consensus statement from the Latin American Society of Pediatric Infectious Diseases (SLIPE).

Expert review of vaccines·2026
Same author

Anticipating impact of implementing PCV20 or PCV21 vaccines for older adults in the immunisation programme for invasive pneumococcal disease, using nationwide surveillance data, Israel, 2009 to 2024.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Is the interplay between maternal Tdap and pneumococcal conjugate vaccines relevant to infant pneumococcal carriage?

The Journal of infectious diseases·2026
Same author

Economic evaluation of combination vaccines: Enabling a more comprehensive assessment of their benefits and challenges.

Vaccine·2026
Same author

What is driving the resurgence and persistence of vaccine-targeted pneumococcal serotypes?-Serotype 19F as the paradigm.

PLoS pathogens·2026
Same author

Correction: Estimating the Value of Combination Vaccines: A Methodological Framework.

PharmacoEconomics·2026
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Related Experiment Video

Updated: Jul 1, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

Serotypes and pathogens in paediatric pneumonia.

William P Hausdorff1, Ron Dagan

  • 1GlaxoSmithKline Biologicals s.a., Rue de l'Institut, 89, B-1330 Rixensart, Belgium. william.p.hausdorff@gsk.com

Vaccine
|September 20, 2008
PubMed
Summary
This summary is machine-generated.

New vaccines may soon combat childhood pneumonia caused by pneumococcus and non-typable Haemophilus influenzae (NTHi). Understanding pathogen importance is crucial for estimating vaccine impact, though NTHi

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Experiment Videos

Last Updated: Jul 1, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Microbiology

Background:

  • Pneumonia is a leading cause of child mortality globally.
  • Multiple pathogens, including Streptococcus pneumoniae and non-typable Haemophilus influenzae (NTHi), cause pediatric pneumonia.
  • New vaccines targeting pneumococcus and NTHi are nearing global availability.

Purpose of the Study:

  • To evaluate the relative importance of specific pneumococcal serotypes and NTHi as causative agents of pediatric pneumonia.
  • To inform the projected impact of newly available conjugate vaccines on childhood pneumonia.

Main Methods:

  • Systematic review of published studies on pediatric pneumonia etiology.
  • Analysis of the contribution of specific Streptococcus pneumoniae serotypes to pneumonia.
  • Assessment of the role of non-typable Haemophilus influenzae (NTHi) in pneumonia.

Main Results:

  • Emerging conjugate vaccines, particularly those including serotype 1, show significant potential for preventing childhood pneumonia due to expanded serotype coverage.
  • The precise contribution of NTHi to the overall burden of pediatric pneumonia remains to be fully elucidated.

Conclusions:

  • Vaccine strategies targeting pneumococcus, especially with broad serotype coverage, are promising for reducing childhood pneumonia.
  • Further research is needed to clarify the etiological role of NTHi in pediatric pneumonia to optimize prevention efforts.